Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Micoli

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Vaccine|January 13, 2026
Microneedle array patch delivery of Shigella flexneri 2a GMMAYoona Choi, In-Jeong Choi, Doo Hee Shim, et al.
Msphere|April 16, 2025
Protein-specific immune response elicited by the <i>Shigella sonnei</i> 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to <i>Shigella</i>Arlo Z Randall, Valentino Conti, Usman Nakakana, et al.
Mbio|March 8, 2018
IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <i>Salmonella</i> Develop at Discordant RatesAnna E Schager, C Coral Dominguez-Medina, Francesca Necchi, et al.
The Journal of Infectious Diseases|June 10, 2024
Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 StudyIsabel Leroux-Roels, Cathy Maes, Francesca Mancini, et al.
Eclinicalmedicine|August 25, 2021
Efficacy, safety, and immunogenicity of the <i>Shigella sonnei</i> 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adultsRobert W Frenck, Valentino Conti, Pietro Ferruzzi, et al.
Frontiers in Immunology|February 16, 2024
Age-dependent acquisition of IgG antibodies to <i>Shigella</i> serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccinationMelissa C Kapulu, Esther Muthumbi, Edward Otieno, et al.
Frontiers in Immunology|April 10, 2023
Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responsesSiân E Jossi, Melissa Arcuri, Areej Alshayea, et al.
Vaccine|March 19, 2024
Vaccine value profile for Klebsiella pneumoniaeZiyaad Dangor, Nicole Benson, James A Berkley, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2025
A multifunctional anti-O-Antigen human monoclonal antibody protects against <i>Shigella sonnei</i> infection in vivoMatteo Ridelfi, Giacomo Vezzani, Emanuele Roscioli, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Vaccine|January 13, 2026
Microneedle array patch delivery of Shigella flexneri 2a GMMAYoona Choi, In-Jeong Choi, Doo Hee Shim, et al.
Msphere|April 16, 2025
Protein-specific immune response elicited by the <i>Shigella sonnei</i> 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to <i>Shigella</i>Arlo Z Randall, Valentino Conti, Usman Nakakana, et al.
Mbio|March 8, 2018
IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal <i>Salmonella</i> Develop at Discordant RatesAnna E Schager, C Coral Dominguez-Medina, Francesca Necchi, et al.
The Journal of Infectious Diseases|June 10, 2024
Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 StudyIsabel Leroux-Roels, Cathy Maes, Francesca Mancini, et al.
Eclinicalmedicine|August 25, 2021
Efficacy, safety, and immunogenicity of the <i>Shigella sonnei</i> 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adultsRobert W Frenck, Valentino Conti, Pietro Ferruzzi, et al.
Frontiers in Immunology|February 16, 2024
Age-dependent acquisition of IgG antibodies to <i>Shigella</i> serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccinationMelissa C Kapulu, Esther Muthumbi, Edward Otieno, et al.
Frontiers in Immunology|April 10, 2023
Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responsesSiân E Jossi, Melissa Arcuri, Areej Alshayea, et al.
Vaccine|March 19, 2024
Vaccine value profile for Klebsiella pneumoniaeZiyaad Dangor, Nicole Benson, James A Berkley, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2025
A multifunctional anti-O-Antigen human monoclonal antibody protects against <i>Shigella sonnei</i> infection in vivoMatteo Ridelfi, Giacomo Vezzani, Emanuele Roscioli, et al.
Pageof 13